Status:
COMPLETED
Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C
Lead Sponsor:
Kyoto University
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
20-70 years
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of low-dose interferon-alfa-2b plus ribavirin compared to the standard-dose of the same combination in patients with chronic hepatitis ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Chronic Hepatitis C. Must be infected with genotype 1b viruses
Exclusion
- Hemoglobin levels\<8.5g/dL,
- Platelet counts\<50,000/mm3,
- Total polymorphonuclear counts\<1000/mm3
- Pregnancy,
- Renal dysfunction,
Key Trial Info
Start Date :
December 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00216775
Start Date
December 1 2004
End Date
May 1 2008
Last Update
September 2 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology and Hepatology, Kyoto University Hospital
Kyoto, Japan, 606-8507
2
Kitano Hospital
Osaka, Japan
3
Osaka Red Cross Hospital
Osaka, Japan
4
Wakayama Red Cross Hospital
Wakayama, Japan